New Wave Holdings Corp.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- New Wave Holdings Corp. (OTCPK: TRMNF) operates as an investment issuer focused on supporting innovative companies in esports, artificial intelligence, blockchain, Web3, nutraceuticals, psychedelics, and natural wellness sectors; through its subsidiary Way of Will Inc., it offers aromatherapy products derived from natural aromatic plant extracts and essential oils, functional mushroom powders and capsules blending five immunity-boosting mushrooms, strengthening nail and cuticle serums, massage oils, deodorants, hand washes, all-natural SPF lotions, and cruelty-free eco-friendly health and beauty items distributed via e-commerce platforms including Amazon, Walmart.com, Whole Foods, Target.com, and subscription services like TheraBox and FabFitFun; the company provides capital, advisory services, and strategic support to esports teams, organizations, events, platforms, technologies, and tools, with operations targeting customers in Canada, the United States, United Kingdom, and Europe. Founded in 2006 and headquartered in Toronto, Ontario, Canada, with a recent shift to Suite 1600, 409 Granville Street, Vancouver, British Columbia, the company pursues vertical integration for high-margin business models encompassing in-house manufacturing, B2C sales, and expanded retail channels. Recent developments include completing a non-brokered private placement raising $385,000 in May 2025 to fund portfolio investments in AI, blockchain, Web3, and existing ventures; announcing in June 2025 a name change to Humanoid Global Holdings Corp., effective June 25, 2025, alongside another non-brokered private placement of units; acquiring Way of Will Inc. in December 2020 for aromatherapy expansion, a 75% interest in Anahit Therapeutics Ltd. by September 2020 for psychedelic research on psilocybin, LSD, MDMA, and ketamine treatments, and a 50% stake earlier that year; launching functional mushroom products in 2021; partnering with N2 Logics Inc. and TJXX for U.S. retail distribution; and pursuing GMP certification, facility expansions, and Amazon optimizations targeting 20-350% sales growth.
Humanoid Global Unaware of Material Change
Humanoid Global Announces Advertising Agreements
Humanoid Global Announces Closing of Special Warrant Financing
Humanoid Global Enters into Memorandum of Understanding with Torus Talent to Establish Strategic Partnership for Talent Recruitment
Humanoid Global Announces Commitment to a Strategic Investment in Apptronik, a Leader in AI Robotics and Human-Centered Design
Humanoid Global Welcomes Olivier Vincent to its Investment Advisory Board
Humanoid Global Announces Commitment to a Strategic Investment in Agility Robotics, Developers of One of the World's First Commercially Deployed Humanoid Robot
Humanoid Global Announces CEO Transition
Humanoid Global Announces Uplisting to the OTCQB Market
Humanoid Global Welcomes Dr. Ahad Armin to its Technical Advisory Committee
Humanoid Global Appoints Dr. Yue Hu to Humanoid Technical Advisory Committee
Humanoid Global Announces Closing of Private Placement
Humanoid Global Announces Increase in Private Placement
New Wave Announces Non-Brokered Private Placement of Units
CSE Bulletin: Name and Symbol Change - New Wave Holdings Corp. (NWAI)
New Wave Announces Effective Date for Name Change
New Wave Announces Investment in Cartwheel Robotics, an Advanced Robotics Company Seeking to Build Humanoids for Humans
New Wave Announces Proposed Name Change and Reiterates Its Investment Policy
NEW WAVE ANNOUNCES Closing of Non-Brokered Private Placement of Units
NEW WAVE ANNOUNCES Non-Brokered Private Placement of Units